Loss-of-function variants in CFAP57 , SEPTIN4 , SPEM2 , and CFAP46
Shoaib Nawaz, Hiroaki Kitakaze, Maha A Abdulla, Nida Khan, Haruhiko Miyata, Mohamed Nadhir Djekidel, Manar Ata, Yuki Kaneda, Hammal Khan, Ihsan Khan, Maria Esteves, Geethanjali Devadoss Gandhi, Fadi Choucair, Shabir Hussain, Elbay Aliyev, Yuki Hatanaka, Yuma Kujime, Go Tsujimura, Takahiro Imanaka, Sohei Kuribayashi, Norichika Ueda, Mohamed M Arafa, Haitham T Elbardisi, Kentaro Takezawa, Shinichiro Fukuhara, Norio Nonomura, Abbirami Sathappan, Abdul Rahman Salhab, Johnny Awwad, Imran Ullah, Khalid Fakhro, Masahito Ikawa, Matteo A AvellaAbstract
STUDY QUESTION
What are the genetic causes of asthenoteratozoospermia in consanguineous families, and what is the specific role of cilia- and flagella-associated proteins (CFAP) 46 in mammalian spermiogenesis?
SUMMARY ANSWER
CFAP46 is a central apparatus protein essential for sperm flagellar assembly and head remodeling.
WHAT IS KNOWN ALREADY
Asthenoteratozoospermia is a genetically heterogeneous condition characterized by reduced sperm motility and abnormal morphology. While several CFAPs are known to support axonemal organization, the functional role of CFAP46 in mammals remained uncharacterized prior to this study.
STUDY DESIGN, SIZE, DURATION
We performed whole-genome or whole-exome sequencing on 13 consanguineous families affected by primary male infertility. Functional validation was conducted using three CRISPR/Cas9-engineered mouse models: a null allele, a FLAG-tagged knock-in, and a humanized patient-specific nonsense allele.
PARTICIPANTS/MATERIALS, SETTING, METHODS
Genomic DNA from affected individuals and fertile relatives was analyzed by NGS and validated via Sanger sequencing. Mouse phenotypes were characterized through sperm analysis, immunofluorescence, and electron microscopy. Protein interactions were identified via immunoprecipitation and mass spectrometry. Additionally, a gene-level burden analysis was applied to unresolved cases across 345 spermiogenesis-associated genes.
MAIN RESULTS AND THE ROLE OF CHANCE
We identified homozygous loss-of-function variants in CFAP46, CFAP57, SEPTIN4, and SPEM2 segregating with infertility. Cfap46-deficient males were infertile due to significantly decreased sperm count, motility, and severe axonemal disruptions. CFAP46 was found to form an in vivo complex with CFAP54, CFAP74, and CFAP221. In families without a monogenic cause, affected individuals harbored a significantly higher burden of rare deleterious variants (4–16 genes) compared to fertile controls.
LARGE SCALE DATA
Large-scale datasets and scripts are available via GitHub (https://github.com/sirusb/Nawaz_et_al_scripts).
LIMITATIONS, REASONS FOR CAUTION
While functional mouse data strongly supports the identified variants, the rare-variant burden analysis identifies associations that require further functional validation to confirm specific oligogenic interactions.
WIDER IMPLICATIONS OF THE FINDINGS
This study establishes CFAP46 as a regulator of mammalian spermiogenesis and suggests that, beyond monogenic defects, aggregated rare-variant burden may also contribute to male infertility. These findings refine the genetic basis of asthenoteratozoospermia, supporting precise molecular diagnosis, individualized prognostic counseling, and informed use of assisted reproduction (e.g. ICSI) in affected couples.
FUNDING
This work was supported by Sidra Medicine grant SDR400185 (to M.A.A.), the FERTILITY-IQ Study and Qatar National Research Fund (QNRF) grant NPRP12S-0318-190394 (to M.A.A. and K.F.), the Qatar Research, Development and Innovation (QRDI) grant GSRA12-I-0311-250014 (to M.A.Abd.), the Quaid-i-Azam University Research Project (URF-QAU) 2020-21 (to I.U.), Japan Society for the Promotion of Science KAKENHI grants JP24K12461 (to H.K.), JP23K18328 (to H.M.), and JP21H05033 and JP23K20043 (to M.I.), Japan Agency for Medical Research and Development (AMED) grants JP23jf0126001 and JP26gn0110011 (to M.I.), and JSRM Ferting Grant 2025 (to H.K.). Open access funding was provided by the Qatar National Library.
DISCLOSURES
The authors declare no competing interests.